Hethcote Herbert W, Horby Peter, McIntyre Peter
Department of Mathematics, University of Iowa, 14 MacLean Hall, Iowa City, IA 52242, USA.
Vaccine. 2004 Jun 2;22(17-18):2181-91. doi: 10.1016/j.vaccine.2003.11.053.
High levels of notified pertussis in adolescents and adults, persisting severe disease (hospitalization and deaths) in infants despite high childhood immunization coverage, together with the availability of adult-formulated pertussis vaccines, have made alternate strategies for vaccine control of pertussis an important issue in Australia. An age-structured computer simulation model was used to compare the likely effects of adopting different vaccination strategies in Australia on pertussis transmission by age group over a 50 year time period. Epidemiological parameters and vaccination coverage in Australia were estimated from previous pertussis modeling studies and existing data. In the simulations, replacing the pertussis booster at 18 months with a booster dose for adolescents at an age between 12 and 17 years, assuming 80% coverage, led to decreases in pertussis cases of 30% in children of ages 0-23 months (who have the highest complication rates) and of 25% in adolescents, but an increase of 15% in cases in 2-4-year-old children. The simulations did not suggest any shift of pertussis cases into the adult child-bearing years. Varying parameter values in the simulations in a series of sensitivity analyses showed the model predictions to be robust over a plausible range. The results of these simulations suggest that the recent change in the Australian pertussis vaccination schedule, replacing the 18 month dose with a pertussis booster in 15-17-year-old adolescents, is very likely to reduce overall pertussis incidence in Australia without increasing the cost of the current vaccine program.
青少年和成人中百日咳报告病例数居高不下,尽管儿童免疫接种覆盖率很高,但婴儿中仍存在严重疾病(住院和死亡),再加上有成人剂型的百日咳疫苗,这使得百日咳疫苗控制的替代策略成为澳大利亚的一个重要问题。一个按年龄结构的计算机模拟模型被用来比较在澳大利亚采用不同疫苗接种策略对50年期间各年龄组百日咳传播的可能影响。澳大利亚的流行病学参数和疫苗接种覆盖率是根据以前的百日咳建模研究和现有数据估算的。在模拟中,假设覆盖率为80%,用12至17岁青少年的加强剂量替代18个月龄时的百日咳加强剂,导致0至23个月龄儿童(并发症发生率最高)的百日咳病例数减少30%,青少年中的病例数减少25%,但2至4岁儿童中的病例数增加15%。模拟结果并未表明百日咳病例会转移到成年育龄期。在一系列敏感性分析中改变模拟中的参数值,结果表明模型预测在合理范围内是稳健的。这些模拟结果表明,澳大利亚最近改变百日咳疫苗接种计划,用15至17岁青少年的百日咳加强剂替代18个月龄时的剂量,很可能会降低澳大利亚百日咳的总体发病率,而不会增加当前疫苗计划的成本。